— Know what they know.
Not Investment Advice

HLS.AX ASX

Healius Limited
1W: +4.0% 1M: -14.1% 3M: +2.6% YTD: -54.3% 1Y: -53.5% 3Y: -76.9% 5Y: -87.3%
A$0.40 ($0.28)
+0.01 (+1.77%)
 
Weekly Expected Move ±11.6%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 39 · A$286.8M mcap · 567M float · 0.912% daily turnover

Income Trends

Revenue
$1.4B +2.2% ▲
5Y CAGR: -6.3%
Gross Profit
$254M -36.3% ▼
5Y CAGR: -13.6%
Operating Income
$30M +15000.0% ▲
5Y CAGR: -34.8%
Net Income
-$416M -174.9% ▼
EPS (Diluted)
$-0.57 +20.8% ▲
EBITDA
$30M -3.2% ▼
5Y CAGR: -42.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$2.3B$1.7B$1.7B$1.3B$1.4B
YoY Growth+20.4%-25.4%+2.3%-23.0%+2.2%
Cost of Revenue$1.5B$1.4B$224M$946M$1.1B
Gross Profit$779M$342M$1.5B$399M$254M
Gross Margin34.0%20.0%87.2%29.7%18.5%
R&D Expenses$0$0$0$0$0
SG&A Expenses$305M$247M$931M$60M$224M
Operating Expenses$305M$244M$1.5B$60M$224M
Operating Income$474M$98M$66M$200K$30M
Operating Margin20.7%5.7%3.8%0.0%2.2%
Interest Expense$49M$62M$71M$65M$49M
Income Before Tax$415M-$397M-$650M-$592M-$378M
Tax Expense$122M-$17M-$14M$29M$31M
Net Income$308M-$368M-$646M-$151M-$416M
Net Margin13.5%-21.5%-37.0%-11.2%-30.3%
EPS (Diluted)$0.46$-0.61$-0.98$-0.72$-0.57
EBITDA$735M-$58M-$298M$31M$30M
Shares Outstanding630M616M660M726M726M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms